Therapy of Niacin for Rheumatoid Arthritis

Summary

This study is a study to evaluate the safety and efficacy of administering niacin sustained-release capsules to rheumatoid arthritis with hyperlipidemia patients. Sixty patients were randomly assigned to niacin or placebo for 12 weeks, followed by niacin for 12 weeks. Changes in disease activity score, immune cell subtypes, markers of intestinal damage, intestinal flora, and other laboratory indicators will be monitored.

Timeline

Start

2025-05-28

Primary completion

2027-01-03

Completion

2027-06-15

Drugs

Indications